Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Operating Leases (2019 - 2022)

Quantum Biopharma recorded quarterly Operating Leases of $38004.0 in Q4 2022, down 85.12% quarter-over-quarter from $255356.0 in Q4 2021, and down 85.12% year-over-year from $255356.0 in Q4 2021.

Quantum Biopharma's Operating Leases history runs 4 years deep, the most recent figure standing at $38004.0 for Q4 2022.

  • In Q4 2022, Operating Leases fell 85.12% year-over-year to $38004.0; the TTM figure through Dec 2022 stood at $38004.0 (down 85.12% YoY), while the FY2022 annual figure was $38004.0, down 85.12% from the prior year.
  • Operating Leases came in at $38004.0 for Q4 2022 at Quantum Biopharma, down from $255356.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $255356.0 in Q4 2021 to a low of $38004.0 in Q4 2022.
  • A 4-year average of $132604.6 and a median of $118529.1 in 2019 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases soared 102.72% in 2021 and tumbled 85.12% in 2022, its largest moves.
  • Quantum Biopharma's Operating Leases stood at $111096.2 in 2019, then rose by 13.38% to $125962.0 in 2020, then jumped by 102.72% to $255356.0 in 2021, then sank by 85.12% to $38004.0 in 2022.
  • According to Business Quant data, Operating Leases over the past three periods registered $38004.0, $255356.0, and $125962.0 for Q4 2022, Q4 2021, and Q4 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 38,004.00
Dec 31, 2021 255,356.00
Dec 31, 2020 125,962.00
Dec 31, 2019 111,096.22